Wall Street slides on fears of likely U.S.-China tech cold war
May 23, 2019Novartis CEO sees chance to accelerate profit margin target
May 23, 2019Novartis CEO sees China M&A hampered by data, regulatory standards
at
Novartis Chief Executive Vas Narasimhan said takeover targets in China for global pharmaceuticals companies are scarce due to little drug discovery by local firms, worries over data quality and regulatory standards in the most-populous country.
Powered by WPeMatico
